Riverwater Partners’s DarioHealth DRIO Stock Holding History

Riverwater Partners’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-634	Closed	-$164K	–	133
2021 Q4	$164K	Buy	+634	New	+$193K	0.15%	209

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverwater Partners's DRIO Position: Q1 2022 in Review

Riverwater Partners sold out of DarioHealth (DRIO) in Q1 2022, closing a stake of 634 shares — an estimated $164K sold.

Riverwater Partners first reported a position in DRIO in Q4 2021 and held it in 1 quarter. The position peaked at $164K in Q4 2021. 63 funds tracked by Wall St. Rank hold DRIO as of Q1 2022.

Riverwater Partners reported no remaining DarioHealth position as of Q1 2022 after selling out during the quarter.
Riverwater Partners sold 634 DarioHealth shares in Q1 2022, an estimated $164K.
Riverwater Partners first reported a position in DarioHealth in Q4 2021 and held it in 1 quarter.
Riverwater Partners's DarioHealth position peaked at $164K in Q4 2021.
63 funds tracked by Wall St. Rank held DarioHealth as of Q1 2022.

Based on Riverwater Partners's 13F filing for Q1 2022, filed 2 May 2022.